Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1991 2
1992 1
1994 6
1995 2
1996 1
1997 3
1998 1
1999 1
2000 1
2003 1
2004 4
2005 1
2006 5
2007 7
2008 11
2009 7
2010 7
2011 12
2012 8
2013 2
2014 5
2015 8
2016 3
2017 6
2018 4
2019 3
2020 3
2021 10
Text availability
Article attribute
Article type
Publication date

Search Results

110 results
Results by year
Filters applied: . Clear all
Page 1
Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and Bevacizumab.
Basho RK, Gilcrease M, Murthy RK, Helgason T, Karp DD, Meric-Bernstam F, Hess KR, Herbrich SM, Valero V, Albarracin C, Litton JK, Chavez-MacGregor M, Ibrahim NK, Murray JL 3rd, Koenig KB, Hong D, Subbiah V, Kurzrock R, Janku F, Moulder SL. Basho RK, et al. Among authors: albarracin c. JAMA Oncol. 2017 Apr 1;3(4):509-515. doi: 10.1001/jamaoncol.2016.5281. JAMA Oncol. 2017. PMID: 27893038 Clinical Trial.
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer.
Ai D, Yao J, Yang F, Huo L, Chen H, Lu W, Soto LMS, Jiang M, Raso MG, Wang S, Bell D, Liu J, Wang H, Tan D, Torres-Cabala C, Gan Q, Wu Y, Albarracin C, Hung MC, Meric-Bernstam F, Wistuba II, Prieto VG, Sahin AA, Ding Q. Ai D, et al. Among authors: albarracin c. Mod Pathol. 2021 Apr;34(4):710-719. doi: 10.1038/s41379-020-00692-8. Epub 2020 Oct 3. Mod Pathol. 2021. PMID: 33011748
Male Mammary Paget Disease: A Tale of 2 Contrasting Cases.
Roy M, Teshome M, Damodaran S, Sahin AA, Khazai L, Arribas E, Candelaria RP, Scoggins ME, Lane DL, Giordano SH, Albarracin CT, Prieto VG, Nagarajan P. Roy M, et al. Among authors: albarracin ct. Am J Dermatopathol. 2020 Dec;42(12):981-985. doi: 10.1097/DAD.0000000000001799. Am J Dermatopathol. 2020. PMID: 33289978
Triple-negative breast cancer: what the radiologist needs to know.
Whitman GJ, Albarracin CT, Gonzalez-Angulo AM. Whitman GJ, et al. Among authors: albarracin ct. Semin Roentgenol. 2011 Jan;46(1):26-39. doi: 10.1053/ Semin Roentgenol. 2011. PMID: 21134526 Review. No abstract available.
DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes.
Kuerer HM, Smith BD, Chavez-MacGregor M, Albarracin C, Barcenas CH, Santiago L, Edgerton ME, Rauch GM, Giordano SH, Sahin A, Krishnamurthy S, Woodward W, Tripathy D, Yang WT, Hunt KK. Kuerer HM, et al. Among authors: albarracin c. J Cancer. 2017 Aug 22;8(14):2653-2662. doi: 10.7150/jca.20871. eCollection 2017. J Cancer. 2017. PMID: 28928852 Free PMC article. Review.
Not all patients with a diagnosis of a radial scar require excision.
Eghtedari M, Le-Petross H, Babiera GV, Albarracin CT, Hess KR, Woodtichartpreecha P, Whitman GJ. Eghtedari M, et al. Among authors: albarracin ct. Breast J. 2019 Jul;25(4):792-794. doi: 10.1111/tbj.13329. Epub 2019 May 13. Breast J. 2019. PMID: 31087426 No abstract available.
Imaging Features of Triple Negative Breast Cancer and the Effect of BRCA Mutations.
Karbasian N, Sohrabi S, Omofoye TS, Le-Petross H, Arun BK, Albarracin CT, Hess KR, Gutierrez-Barrera AM, Whitman GJ. Karbasian N, et al. Among authors: albarracin ct. Curr Probl Diagn Radiol. 2021 May-Jun;50(3):303-307. doi: 10.1067/j.cpradiol.2020.01.011. Epub 2020 Jan 8. Curr Probl Diagn Radiol. 2021. PMID: 32033821 Review.
Rare Malignant Tumors of the Breast.
Miller T, Albarracin C, Carkaci S, Whitman GJ, Adrada BE. Miller T, et al. Among authors: albarracin c. J Clin Imaging Sci. 2015 Oct 30;5:58. doi: 10.4103/2156-7514.168711. eCollection 2015. J Clin Imaging Sci. 2015. PMID: 26664775 Free PMC article.
110 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page